Title IV: Veterinary medicinal products

Advertising of veterinary medicinal products to the public is authorised. However, it is prohibited for prescription medicines in application of article L. 5143-5.

In all cases, advertising must not be misleading or undermine the protection of human or animal health. It must present the medicinal product objectively and encourage its proper use. It must never make veterinary consultation appear superfluous, nor be accompanied by promises or advantages of any kind, nor use attestations or expert opinions.

Advertising of veterinary medicinal products to the natural or legal persons mentioned in article R. 5141-83 must include at least the following information: 1° The name of the medicinal product ; 2° The intended species ; 3° The qualitative and quantitative composition of the active ingredients; 4° The rules governing the prescription and supply of the medicinal product; 5° The therapeutic indications, contra-indications and side-effects included in or annexed to…

The information contained in the advertisement mentioned in article R. 5141-85 for a veterinary medicinal product is consistent with the information contained in the summary of product characteristics mentioned in article R. 5141-15. This information is accurate, up-to-date, verifiable and sufficiently complete to enable the recipient to form a personal opinion of the therapeutic value of the medicinal product. All written information must be perfectly legible by the recipient of…

When permitted under article R. 5141-84, advertising of veterinary medicinal products to the public: 1° Is designed in such a way that the advertising nature of the message is obvious and the product is clearly identified as a veterinary medicinal product; 2° Contains at least : a) The name of the veterinary medicinal product ; b) Information essential for the proper use of the veterinary medicinal product; c) An express…

For the advertising mentioned in articles R. 5141-83 and R. 5141-84, the advertising texts and documents must be filed with the Director General of the Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail, by any means giving a date certain, two months before they are distributed.

Advertising for … is subject to prior authorisation from the Director General of the Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail: 1° Antibiotics ; 2° Veterinary medicinal products subject to a risk management plan ; 3° Medicinal products presented as favouring the diagnosis, prevention or treatment of diseases classified as first category health hazards in the nomenclature provided for inarticle L. 201-1 of the Rural…

As long as the information concerning each medicinal product reproduces in full the summary of product characteristics mentioned in article R. 5141-15, publications intended to reference veterinary medicinal products are exempt from the authorisation provided for in article R. 5141-86. This exemption does not apply to publications by marketing authorisation holders and companies exploiting veterinary medicinal products.

Advertising of self-vaccines for veterinary use is prohibited. However, holders of the authorisation referred to in article L. 5141-12 may distribute information about their activities to veterinarians only. This information must comply with the terms of the authorisation provided for in article R. 5141-132.

The companies referred to in article R. 5142-1 are prohibited from directly or indirectly providing users and persons authorised to prescribe or dispense medicinal products with premiums, objects or products of any kind or from granting direct or indirect material advantages other than the price conditions in force. However, donations intended to encourage research and teaching for the benefit of public establishments or foundations recognised as being in the public…